Your browser doesn't support javascript.
loading
Efficient Process Development of Abiraterone Acetate by Employing Design of Experiments.
Komati, Shravan Kumar; Madhra, Mukesh Kumar; Manda, Amarendhar; Venkata Annapurna, Sasikala Cheemalapati; Senadi, Gopal Chandru; Maruthapillai, Arthanareeswari; Bandichhor, Rakeshwar.
Afiliación
  • Komati SK; Department of Chemistry, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur 603203, Tamil Nadu, India.
  • Madhra MK; Dr. Reddy's Laboratories Ltd., Integrated Product Development, Innovation Plaza, Bachupally, Hyderabad 500090, Telangana, India.
  • Manda A; Dr. Reddy's Laboratories Ltd., Integrated Product Development, Innovation Plaza, Bachupally, Hyderabad 500090, Telangana, India.
  • Venkata Annapurna SC; Department of Chemistry, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur 603203, Tamil Nadu, India.
  • Senadi GC; Dr. Reddy's Laboratories Ltd., Integrated Product Development, Innovation Plaza, Bachupally, Hyderabad 500090, Telangana, India.
  • Maruthapillai A; Dr. Reddy's Laboratories Ltd., Integrated Product Development, Innovation Plaza, Bachupally, Hyderabad 500090, Telangana, India.
  • Bandichhor R; Department of Chemistry, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur 603203, Tamil Nadu, India.
ACS Omega ; 9(27): 29453-29470, 2024 Jul 09.
Article en En | MEDLINE | ID: mdl-39005825
ABSTRACT
This article describes an efficient process for the synthesis of abiraterone acetate by employing Quality by Design (QbD) principles and statistical design of experiments (DoE). It focuses on the identification of critical quality attributes (CQAs), the relationship between CQAs and material attributes (MAs), and critical process parameters (CPPs) for the synthesis of hydrazone, vinyl iodide intermediates, and final product. Risk assessment is employed to identify the probable critical factors involved in each chemical transformation. The design of experiments approach aided in controlling the formation of critical impurities in all three reactions, namely, deacylated impurity in the hydrazone intermediate, 17-methyl impurity in the vinyl iodide intermediate, and hydroxy and diene impurities in the final API. The process was developed such that we achieved 95, 85, and 82% selectivity and 99, 96, and 99% purity in hydrazone, vinyl iodide intermediate, and final API, respectively. This reflects improved throughput from 25 to 57% as a result of the subtle interplay of critical process parameters identified by DoE studies.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: ACS Omega Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: ACS Omega Año: 2024 Tipo del documento: Article